Cargando…

Remdesivir: Elevated AST and ALT levels following off-label therapy: 4 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644402/ http://dx.doi.org/10.1007/s40278-020-85037-3

Ejemplares similares

Tocilizumab: Elevated AST and ALT following off label therapy: 11 case reports
Publicado: (2021)

Remdesivir: Elevated ALT level and lack of efficacy following off-label use: 13 case reports
Publicado: (2021)

Ribavirin: Mild elevation of bilirubin and AST/ALT: case report
Publicado: (2016)

Convalescent-anti-sars-cov-2-plasma/remdesivir: Sinus bradycardia, elevated ALT and off-label use: case report
Publicado: (2021)

Remdesivir: Acute kidney injury and elevated ALT level: 2 case reports
Publicado: (2022)

Antivirals/glucocorticoids: Diabetes mellitus and ALT elevation following off-label use in COVID-19: case report
Publicado: (2020)

Remdesivir: Sinus bradycardia and lack of efficacy following off-label use: 4 case reports
Publicado: (2022)

Amiodarone/chloroquine/remdesivir interaction: Hepatotoxicity and off-label therapy: case report
Publicado: (2021)

Can elevated concentrations of ALT and AST predict the risk of ‘recurrence’ of COVID-19?
por: Chen, L. Z., et al.
Publicado: (2020)

Elevated AST/ALT ratio is associated with all‐cause mortality and cancer incident
por: Chen, Wangyang, et al.
Publicado: (2022)

Aciclovir/dexamethasone/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2022)

Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke
por: Ahmadabad, Mona Asghari, et al.
Publicado: (2022)

Dexamethasone/remdesivir/warfarin interaction: Elevation of international normalised ratio and off-label use: 2 case reports
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Methylprednisolone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Dexamethasone/enoxaparin-sodium/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Remdesivir: Renal dysfunction and liver dysfunction following off-label use: 2 case reports
Publicado: (2022)

Remdesivir/methylprednisolone/convalescent-anti-SARS-CoV-2-plasma: Elevated aminotransferase levels and off-label use: case report
Publicado: (2021)

Remdesivir: Elevated transaminase level: case report
Publicado: (2022)

Hydroxychloroquine: Elevated aminotransferase levels following off-label use: case report
Publicado: (2021)

Azithromycin/ceftriaxone/remdesivir: Bradycardia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Dexamethasone/remdesivir/rituximab: Hypotension, dyspnoea and lack of efficacy following off-label use: case report
Publicado: (2021)

Favipiravir: Fever and elevated uric acid level following off-label therapy: 2 case reports
Publicado: (2021)

Remdesivir/tocilizumab: Drug ineffective and off-label use: 2 case reports
Publicado: (2021)

Apixaban/dexamethasone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Antibacterials/interferon/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/methylprednisolone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

An updated meta-analysis of AST and ALT levels and the mortality of COVID-19 patients
por: Wang, Ying, et al.
Publicado: (2021)

Dexamethasone/metoprolol-succinate/remdesivir: Sinus bradycardia following drug interaction and off label use: case report
Publicado: (2022)

The significance of transaminase ratio (AST/ALT) in acute myocardial infarction
por: Djakpo, Dodji Kossi, et al.
Publicado: (2020)

Dexamethasone/enoxaparin-sodium/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2022)

Gilteritinib/hydroxycarbamide/remdesivir: Neutropenia, lack of efficacy and off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_frscpuqkrin77ejfaui30luqhu